Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Rev Neurol (Paris) ; 168(8-9): 576-84, 2012.
Artigo em Francês | MEDLINE | ID: mdl-22921250

RESUMO

Parkinson's disease is mainly considered as a motor disorder defined by a motor triad. However, various non-motor manifestations may be encountered in Parkinson's disease, including hyposmia, pain, fatigue, sleep disorders, cognitive and behavioral disorders. The pathophysiology of these signs is complex, not univocal and remains poorly understood. Functional imaging techniques either by positron emission tomography, single photon emission tomography or functional magnetic resonance imaging provide an invaluable opportunity to better understand the pathophysiology of these signs. In this paper, we present a review of the recent advances provided by functional imaging in this area.


Assuntos
Diagnóstico por Imagem/métodos , Neuroimagem/métodos , Doença de Parkinson/diagnóstico , Cognição/fisiologia , Depressão/diagnóstico , Depressão/etiologia , Depressão/fisiopatologia , Neurônios Dopaminérgicos/fisiologia , Fadiga/diagnóstico , Fadiga/etiologia , Fadiga/fisiopatologia , Humanos , Transtornos Mentais/diagnóstico , Transtornos Mentais/fisiopatologia , Atividade Motora/fisiologia , Transtornos do Olfato/diagnóstico , Transtornos do Olfato/fisiopatologia , Doença de Parkinson/complicações , Doença de Parkinson/fisiopatologia , Transtornos do Sono-Vigília/diagnóstico , Transtornos do Sono-Vigília/fisiopatologia
2.
J Neurol Neurosurg Psychiatry ; 79(10): 1110-6, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18356249

RESUMO

BACKGROUND: In patients with Parkinson's disease (PD), motor performance may be dramatically improved in urgent and stressful situations. OBJECTIVE: The aim of this PET H(2)(15)O study was to determine the changes in brain activation pattern related to this unconscious increase in motor speed observed in the context of urgency in patients with PD. METHODS: Eight right-handed patients with PD, who had been off medication for at least 12 hours, without tremor, were enrolled. A reaching task with the right hand was performed under three conditions: self-initiated (SI), externally cued (EC) and externally cued-urgent (ECu). RESULTS: (1) Self-initiated movements (SI-EC) revealed activations in the prefrontal cortex bilaterally, the right lateral premotor cortex, anterior cingulate cortex and cerebellum, and the left primary motor cortex and thalamus; (2) Externally driven responses (EC-SI) did not involve any statistically detectable activation; (3) Urgent situations (ECu-EC) engaged the left cerebellum. Compared with a control group previously studied, the cerebellar activation was greater in patients with PD. CONCLUSIONS: This study demonstrates that the increase in movement speed in urgent situations in patients with PD is associated with the recruitment of the left (contralateral) cerebellum. This structure is a key node of the accessory motor circuitry typically recruited by patients with PD to compensate for basal ganglia dysfunction and by healthy subjects to increase movement velocity in urgent motor contexts.


Assuntos
Cerebelo/fisiopatologia , Lateralidade Funcional/fisiologia , Transtornos dos Movimentos/etiologia , Doença de Parkinson/fisiopatologia , Idoso , Cerebelo/irrigação sanguínea , Cerebelo/diagnóstico por imagem , Feminino , Lobo Frontal/irrigação sanguínea , Lobo Frontal/diagnóstico por imagem , Lobo Frontal/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Córtex Motor/diagnóstico por imagem , Córtex Motor/fisiopatologia , Transtornos dos Movimentos/diagnóstico , Doença de Parkinson/complicações , Doença de Parkinson/diagnóstico , Tomografia por Emissão de Pósitrons , Tempo de Reação , Índice de Gravidade de Doença , Tomografia Computadorizada por Raios X
3.
Neurology ; 75(19): 1711-6, 2010 Nov 09.
Artigo em Inglês | MEDLINE | ID: mdl-20926784

RESUMO

OBJECTIVE: Some patients with Parkinson disease (PD) develop pathological gambling when treated with dopamine agonists (DAs). However, little is known about DA-induced changes in neuronal networks that may underpin this drug-induced change in behavior in vulnerable individuals. In this case-control study, we aimed to investigate DA-induced changes in brain activity that may differentiate patients with PD with DA-induced pathological gambling (gamblers) from patients with PD without such a history (controls). METHODS: Following overnight withdrawal of antiparkinsonian medication, patients were studied with H2(15)O PET before and after administration of DA (3 mg apomorphine) to measure changes in regional cerebral blood flow as an index of regional brain activity during a card selection game with probabilistic feedback. RESULTS: We observed that the direction of DA-related activity change in brain areas that are implicated in impulse control and response inhibition (lateral orbitofrontal cortex, rostral cingulate zone, amygdala, external pallidum) distinguished gamblers from controls. DA significantly increased activity in these areas in controls, while gamblers showed a significant DA-induced reduction of activity. CONCLUSIONS: We propose that in vulnerable patients with PD, DAs produce an abnormal neuronal pattern that resembles those found in nonparkinsonian pathological gambling and drug addiction. DA-induced disruption of inhibitory key functions--outcome monitoring (rostral cingulate zone), acquisition and retention of negative action-outcome associations (amygdala and lateral orbitofrontal cortex)--together with restricted access of those areas to executive control (external pallidum)--may well explain loss of impulse control and response inhibition in vulnerable patients with PD, thereby fostering the development of pathological gambling.


Assuntos
Agonistas de Dopamina/farmacologia , Jogo de Azar/psicologia , Rede Nervosa/fisiologia , Inibição Neural/fisiologia , Doença de Parkinson/psicologia , Adulto , Idoso , Antiparkinsonianos/farmacologia , Lobo Frontal/efeitos dos fármacos , Lobo Frontal/fisiologia , Jogo de Azar/diagnóstico , Humanos , Pessoa de Meia-Idade , Rede Nervosa/efeitos dos fármacos , Inibição Neural/efeitos dos fármacos , Doença de Parkinson/diagnóstico , Estimulação Luminosa/métodos , Tomografia por Emissão de Pósitrons/métodos , Valor Preditivo dos Testes
4.
Exp Brain Res ; 179(2): 245-53, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17146649

RESUMO

Parkinson's disease (PD) patients have longer reaction time (RT) than age-matched control subjects. During the last decades, conflicting results have been reported regarding the source of this deficit. Here, we addressed the possibility that experimental inconsistencies originated in the composite nature of RT responses. To investigate this idea, we examined the effect of PD on different processes that compose RT responses. Three variables were manipulated: the signal quality, the stimulus-response compatibility and the foreperiod duration. These variables have been shown to affect, respectively, the ability to extract the relevant features of the stimulus (perceptual stage), the intentional selection of the motor response (cognitive stage) and the implementation of the muscle command (motor stage). Sixteen PD patients were tested on and off-medication and compared with an age and gender-matched control group. Results indicated that degrading the legibility of the response stimulus affected the latency of simple key-press movements more dramatically in the off-medication PD group than in the control population. The stimulus-response compatibility and the foreperiod duration had similar effects in the two groups. Interestingly, the response slowing associated with the degradation of the stimulus was the same whether the patients were on or off dopaminergic medication. This suggests that the high-level perceptual deficits observed in the present study do not have a dopaminergic origin.


Assuntos
Discinesias/etiologia , Discinesias/psicologia , Doença de Parkinson/complicações , Doença de Parkinson/psicologia , Percepção/fisiologia , Adulto , Idoso , Antiparkinsonianos/uso terapêutico , Dopamina/fisiologia , Feminino , Humanos , Levodopa/uso terapêutico , Masculino , Pessoa de Meia-Idade , Movimento/fisiologia , Desempenho Psicomotor/fisiologia , Tempo de Reação/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA